Photosensitizing Agents and the Risk of Non-Melanoma Skin Cancer: A Population-Based Case–Control Study
Open Access
- 1 August 2013
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 133 (8) , 1950-1955
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Analgesic and nonsteroidal anti-inflammatory use in relation to nonmelanoma skin cancer: A population-based case-control studyJournal of the American Academy of Dermatology, 2011
- Photosensitizing Medication Use and Risk of Skin CancerCancer Epidemiology, Biomarkers & Prevention, 2010
- High-ceiling diuretics are associated with an increased risk of basal cell carcinoma in a population-based follow-up studyEuropean Journal of Cancer, 2010
- Use of photosensitising diuretics and risk of skin cancer: a population-based case–control studyBritish Journal of Cancer, 2008
- Reported Use of Photosensitizing Medications and Basal Cell and Squamous Cell Carcinoma of the Skin: Results of a Population-Based Case–Control StudyJournal of Investigative Dermatology, 2007
- The Risk of Cancer Among Patients Previously Hospitalized for Atopic DermatitisJournal of Investigative Dermatology, 2005
- PUVA and cancer risk: the Swedish follow-up studyBritish Journal of Dermatology, 1999
- Oral Psoralen and Ultraviolet-A Light (PUVA) Treatment of Psoriasis and Persistent Risk of Nonmelanoma Skin CancerJNCI: Journal of the National Cancer Institute, 1998
- Likely photosensitizing agents available in the United Kingdom-an updateClinical and Experimental Dermatology, 1996
- Cutaneous photosensitivity diseases induced by exogenous agentsJournal of the American Academy of Dermatology, 1995